0001209191-19-043395.txt : 20190726
0001209191-19-043395.hdr.sgml : 20190726
20190726172630
ACCESSION NUMBER: 0001209191-19-043395
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190613
FILED AS OF DATE: 20190726
DATE AS OF CHANGE: 20190726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galante Joseph C
CENTRAL INDEX KEY: 0001632384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 19978761
MAIL ADDRESS:
STREET 1: 111 TENTH AVENUE
STREET 2: SUITE 200
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-13
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001632384
Galante Joseph C
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2019-06-13
4
P
0
60
6.42
A
11618
D
Common Stock
2019-06-14
4
P
0
60
6.37
A
11678
D
Common Stock
2019-06-17
4
P
0
60
6.33
A
11738
D
Common Stock
2019-06-18
4
P
0
60
6.36
A
11798
D
Common Stock
2019-06-19
4
P
0
60
6.35
A
11858
D
Common Stock
2019-06-20
4
P
0
60
6.33
A
11918
D
Common Stock
2019-06-21
4
P
0
60
6.34
A
11978
D
Common Stock
2019-06-24
4
P
0
60
6.54
A
12038
D
Common Stock
2019-06-25
4
P
0
60
6.56
A
12098
D
Common Stock
2019-06-26
4
P
0
60
6.54
A
12158
D
Common Stock
2019-06-27
4
P
0
60
6.48
A
12218
D
Common Stock
2019-06-28
4
P
0
60
6.49
A
12278
D
Common Stock
2019-07-01
4
P
0
60
6.52
A
12338
D
Common Stock
2019-07-02
4
P
0
60
6.49
A
12398
D
Common Stock
2019-07-03
4
P
0
60
6.46
A
12458
D
Common Stock
2019-07-05
4
P
0
60
6.49
A
12518
D
Common Stock
2019-07-08
4
P
0
60
6.37
A
12578
D
Common Stock
2019-07-09
4
P
0
60
6.15
A
12638
D
Common Stock
2019-07-10
4
P
0
60
6.07
A
12698
D
Common Stock
2019-07-11
4
P
0
60
5.93
A
12758
D
Common Stock
2019-07-12
4
P
0
60
6.01
A
12818
D
Common Stock
2019-07-15
4
P
0
60
5.85
A
12878
D
Common Stock
2019-07-16
4
P
0
60
5.88
A
12938
D
Common Stock
2019-07-17
4
P
0
60
5.85
A
12998
D
Common Stock
2019-07-18
4
P
0
60
5.84
A
13058
D
Common Stock
2019-07-19
4
P
0
60
5.69
A
13118
D
Common Stock
2019-07-22
4
P
0
60
5.75
A
13178
D
Common Stock
2019-07-24
4
P
0
60
5.93
A
13238
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.
Joseph C. Galante by /s/ Michael Bonner as
attorney-in-fact
2019-07-26